Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Rheumatoid Arthritis

  Free Subscription


29.06.2020

13 Ann Rheum Dis
5 Arthritis Res Ther
1 Clin Exp Immunol
5 Clin Exp Rheumatol
8 Clin Rheumatol
2 PLoS One
1 Rheumatol Int
1 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. SANTOS-MORENO P, Chavez-Chavez J, Hernandez-Zambrano SM, Rivera-Triana DP, et al
    Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic.
    Ann Rheum Dis. 2020 Jun 25. pii: annrheumdis-2020-218165.
    PubMed        

  2. EYUBOGLU M
    Inflammatory and non-inflammatory triggers of acute coronary syndromes.
    Ann Rheum Dis. 2020;79:e49.
    PubMed        

  3. WESTERLIND H, Holmqvist M, Ljung L, Frisell T, et al
    Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by Eyuboglu.
    Ann Rheum Dis. 2020;79:e50.
    PubMed        

  4. DAMOISEAUX J, Andrade LEC
    Response to: 'Antinuclear antibodies: mitotic patterns and their clinical associations' by Betancur and Gomez-Puerta.
    Ann Rheum Dis. 2020;79:e64.
    PubMed        

  5. MOISEEV S, Karovaikina E, Novikov PI, Ismailova D, et al
    What rheumatologist should know about Fabry disease.
    Ann Rheum Dis. 2020;79:e71.
    PubMed        

  6. VORDENBAUMEN S, Brinks R, Richter JG, Albrecht K, et al
    Response to 'What rheumatologist should know about Fabry disease' by Moiseev et al.
    Ann Rheum Dis. 2020;79:e72.
    PubMed        

  7. MISHRA D, Chattopadhyay A, Jain S, Dhir V, et al
    TARA study: a new perspective on tapering drugs in RA.
    Ann Rheum Dis. 2020;79:e79.
    PubMed        

  8. VAN MULLIGEN E, Hazes JMW, Weel AEAM, de Jong PHP, et al
    Response to: 'TARA Study: a new perspective on tapering drugs in RA' by Mishra et al.
    Ann Rheum Dis. 2020;79:e80.
    PubMed        

  9. GIANFRANCESCO M, Hyrich KL, Al-Adely S, Carmona L, et al
    Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Ann Rheum Dis. 2020;79:859-866.
    PubMed         Abstract available

  10. SANCHEZ-PIEDRA C, Diaz-Torne C, Manero J, Pego-Reigosa JM, et al
    Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
    Ann Rheum Dis. 2020;79:988-990.
    PubMed        

  11. XU X, He X, Yang Y, Yao M, et al
    Combination of human umbilical cord mesenchymal stem (stromal) cell transplantation with IFN-gamma treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis.
    Ann Rheum Dis. 2020 Jun 19. pii: annrheumdis-2020-217798.
    PubMed         Abstract available

  12. FIGUEROA-PARRA G, Gamboa-Alonso CM, Galarza-Delgado DA
    Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: 'Online management of rheumatoid arthritis during COVID-19 pandemic' by Zhang et al.
    Ann Rheum Dis. 2020 Jun 19. pii: annrheumdis-2020-217631.
    PubMed        

  13. BOZZALLA CASSIONE E, Zanframundo G, Biglia A, Codullo V, et al
    Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al.
    Ann Rheum Dis. 2020 Jun 25. pii: annrheumdis-2020-218193.
    PubMed        


    Arthritis Res Ther

  14. MA MHY, Defranoux N, Li W, Sasso EH, et al
    A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis.
    Arthritis Res Ther. 2020;22:158.
    PubMed         Abstract available

  15. TAKEUCHI T, Tanaka Y, Tanaka S, Kawakami A, et al
    Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan.
    Arthritis Res Ther. 2020;22:155.
    PubMed         Abstract available

  16. JIANG X, Alfredsson L
    Modifiable environmental exposure and risk of rheumatoid arthritis-current evidence from genetic studies.
    Arthritis Res Ther. 2020;22:154.
    PubMed         Abstract available

  17. HA YJ, Lee SM, Mun CH, Kim HJ, et al
    Methotrexate-loaded multifunctional nanoparticles with near-infrared irradiation for the treatment of rheumatoid arthritis.
    Arthritis Res Ther. 2020;22:146.
    PubMed         Abstract available

  18. OTA T, Ota SI, Uchino A, Nagano S, et al
    IgG anti-hinge antibodies against IgG4 F(ab')2 fragments generated using pepsin are useful diagnostic markers for rheumatoid arthritis: implications of the possible roles of metalloproteinases and IgG subclasses in generating immunogenic hinge epitope
    Arthritis Res Ther. 2020;22:161.
    PubMed         Abstract available


    Clin Exp Immunol

  19. CANAVAN M, Marzaioli V, McGarry T, Bhargava V, et al
    Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells.
    Clin Exp Immunol. 2020 Jun 17. doi: 10.1111/cei.13479.
    PubMed         Abstract available


    Clin Exp Rheumatol

  20. KORENDOVYCH V, Fleischhammer J, Tampe B, Nikiphorou E, et al
    Severely destructive unilateral wrist arthritis as a rare variant of rheumatoid arthritis: analysis of clinical and imaging features.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15392.
    PubMed         Abstract available

  21. KAUNDAL U, Khullar A, Leishangthem B, Jain S, et al
    The effect of methotrexate on neutrophil reactive oxygen species and CD177 expression in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15398.
    PubMed         Abstract available

  22. SANCHEZ-CARDENAS G, Contreras-Yanez I, Mendez-Flores S, Merayo-Chalico J, et al
    Toenail abnormalities in rheumatoid arthritis patients are associated with radiographic damage and impact disability: a cross sectional study nested within a cohort.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15106.
    PubMed         Abstract available

  23. MANARA M, Caporali R, Lomater C, Gorla R, et al
    Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study.
    Clin Exp Rheumatol. 2020 Jun 19. pii: 14934.
    PubMed         Abstract available

  24. LIU G, Xu D, He Y, Xu J, et al
    Inhibition of transient receptor potential canonical 6 attenuates fibroblast-like synoviocytes mediated synovial inflammation and joint destruction in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jun 12. pii: 15129.
    PubMed         Abstract available


    Clin Rheumatol

  25. CHENG C, Li C, Zhao T, Yue J, et al
    COVID-19 with rheumatic diseases: a report of 5 cases.
    Clin Rheumatol. 2020;39:2025-2029.
    PubMed         Abstract available

  26. ZARAGOZA-GARCIA O, Guzman-Guzman IP, Moreno-Godinez ME, Navarro-Zarza JE, et al
    PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.
    Clin Rheumatol. 2020 Jun 18. pii: 10.1007/s10067-020-05218.
    PubMed         Abstract available

  27. MENA-VAZQUEZ N, Godoy-Navarrete FJ, Manrique-Arija S, Aguilar-Hurtado MC, et al
    Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.
    Clin Rheumatol. 2020 Jun 16. pii: 10.1007/s10067-020-05227.
    PubMed         Abstract available

  28. XU TS, Jia SY, Li P
    Interleukin-29 and interleukin-28A induce migration of neutrophils in rheumatoid arthritis.
    Clin Rheumatol. 2020 Jun 15. pii: 10.1007/s10067-020-05211.
    PubMed         Abstract available

  29. CAI S, Sun W, Li M, Dong L, et al
    A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
    Clin Rheumatol. 2020 Jun 19. pii: 10.1007/s10067-020-05234.
    PubMed         Abstract available

  30. PARRAGA PRIETO C, Ibrahim F, Campbell R, Chinoy H, et al
    Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis.
    Clin Rheumatol. 2020 Jun 22. pii: 10.1007/s10067-020-05237.
    PubMed         Abstract available

  31. HIGASHIDA-KONISHI M, Izumi K, Tsukamoto M, Ohya H, et al
    Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.
    Clin Rheumatol. 2020 Jun 22. pii: 10.1007/s10067-020-05223.
    PubMed         Abstract available

  32. ASGARI S, Abbasi M, Hamilton K, Chen YP, et al
    A theory-based intervention to promote medication adherence in patients with rheumatoid arthritis: A randomized controlled trial.
    Clin Rheumatol. 2020 Jun 25. pii: 10.1007/s10067-020-05224.
    PubMed         Abstract available


    PLoS One

  33. SACRISTAN JA, Dilla T, Diaz-Cerezo S, Gabas-Rivera C, et al
    Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature.
    PLoS One. 2020;15:e0234705.
    PubMed         Abstract available

  34. ALAM J, Lee A, Lee J, Kwon DI, et al
    Dysbiotic oral microbiota and infected salivary glands in Sjogren's syndrome.
    PLoS One. 2020;15:e0230667.
    PubMed         Abstract available


    Rheumatol Int

  35. WESTHOVENS R, Connolly SE, Margaux J, Vanden Berghe M, et al
    Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study.
    Rheumatol Int. 2020 Jun 17. pii: 10.1007/s00296-020-04619.
    PubMed         Abstract available


    Z Rheumatol

  36. BEIDER S, Flohr S, Gehlert S, Witte T, et al
    [Association of physical activity with fatigue and functional capacity in patients with rheumatoid arthritis].
    Z Rheumatol. 2020 Jun 25. pii: 10.1007/s00393-020-00830.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: